Verapamil hydrochloride
Verapamil hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Verapamil hydrochloride; Generic name: VERAPAMIL HYDROCHLORIDE; Manufacturer: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
| Brand name | Verapamil hydrochloride |
|---|---|
| Generic name | VERAPAMIL HYDROCHLORIDE |
| Manufacturer | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Used for | INDICATIONS AND USAGE Verapamil Hydrochloride Injection, USP is indicated for the following: Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [W-P-W] and Lown-Ganong- Levine [L-G-L] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson- White (W-P-W) and Lown-Ganong-Levine (L-G-L |
| Dosage | DOSAGE AND ADMINISTRATION FOR INTRAVENOUS USE ONLY. VERAPAMIL HYDROCHLORIDE INJECTION SHOULD BE GIVEN AS A SLOW INTRAVENOUS INJECTION OVER AT LEAST A TWO-MINUTE PERIOD OF TIME UNDER CONTINUOUS ELECTROCARDIOGRAPHIC (ECG) AND BLOOD PRESSURE MONITORING. The recommended intravenous doses of verapamil hydrochloride injection are as follows: Adult Initial dose – 5 to 10 mg (0.075 to 0.15 mg/kg body weight) given as an intravenous bolus over at least 2 minutes. Repeat dose – 10 mg (0.15 mg/kg body weig |
| Warnings | WARNINGS VERAPAMIL HYDROCHLORIDE SHOULD BE GIVEN AS A SLOW INTRAVENOUS INJECTION OVER AT LEAST A TWO-MINUTE PERIOD OF TIME (see DOSAGE AND ADMINISTRATION ). Hypotension Verapamil hydrochloride injection often produces a decrease in blood pressure below baseline levels that is usually transient and asymptomatic but may result in dizziness. Systolic pressure less than 90 mm Hg and/or diastolic pressure less than 60 mm Hg was seen in 5% to 10% of patients in controlled U.S. trials in supraventricul |
| Active ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1076a3ef-de02-487f-8117-b4e80495db29 |